Education
About Us
Working with TipRanks
Follow Us
Medical Developments International Limited (AU:MVP)
ASX:MVP
RESEARCH TOOLSreports
MVP Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MVP Stock 12 Month Forecast
Average Price Target
AU$0.71
▲(69.05% Upside)
| Highest Price TargetAU$0.71 | Average Price TargetAU$0.71 | Lowest Price TargetAU$0.71 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bell Potter
Downgraded
03/24/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bell Potter
Downgraded
03/24/25
Best Analysts Covering Medical Developments International Limited
Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MVP Analyst Recommendation Trends
Rating
Aug 22
Oct 22
Feb 23
Sep 23
Mar 25
Strong Buy
1
1
2
2
2
Buy
3
3
1
1
0
Hold
0
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
4
4
3
Each month's total comprises the sum of three months' worth of ratings.
MVP Financial Forecast
MVP Stock Forecast FAQ
What is AU:MVP’s average 12-month price target, according to analysts?
Based on analyst ratings, Medical Developments International Limited’s 12-month average price target is 0.71.
What is AU:MVP’s upside potential, based on the analysts’ average price target?
Medical Developments International Limited has 69.05% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Medical Developments International Limited a Buy, Sell or Hold?
Medical Developments International Limited has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Medical Developments International Limited’s share price target?
The average share price target for Medical Developments International Limited is 0.71. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.71 ,and the lowest forecast is AU$0.71. The average share price target represents 69.05% Increase from the current price of AU$0.42.
The highest analyst share price target is AU$0.71 ,and the lowest forecast is AU$0.71. The average share price target represents 69.05% Increase from the current price of AU$0.42.
What do analysts say about Medical Developments International Limited?
Medical Developments International Limited’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Medical Developments International Limited?
To buy shares of AU:MVP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.